ITEM 2.02 Results of Operations and Financial Condition

On February 12, 2020, Teva Pharmaceutical Industries Ltd. issued a press release announcing its financial results for the period ended December 31, 2019. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and the information contained therein is incorporated herein by reference.

The information included in this Item 2.02 is being furnished to the Securities and Exchange Commission and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01 Financial Statements and Exhibits





(d) Exhibits


Exhibit
  No.      Description of Document
  99.1       Teva Reports 2019 Full Year and Fourth Quarter Financial Results

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses